This compound is primarily used in the European market, and acts as a periferal amino acid decarboxylase inhibitor in fixed dose combination (with L-DOPA) products for the treatment of Parkinsons disease. Chemoswed now offers competitively priced, fully Ph Eur compliant benserazide hydrochloride under DMF/CEP.